Harbin Taxus Bio-Pharmaceutical

Harbin Taxus Bio-Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale production of taxane-based anti-tumor drugs. The company is a major global supplier of paclitaxel, docetaxel, and cabazitaxel, utilizing advanced extraction and semi-synthetic technologies derived from Taxus (yew) plant sources. Its business model encompasses the entire value chain from Taxus cultivation and raw material extraction to the manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. Harbin Taxus is recognized for its high-purity extraction processes and serves both domestic and international markets with oncology therapeutics.